Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Targeting Signaling Pathways in Solid Tumors Part A
- 1st Edition, Volume 385 - April 23, 2024
- Editors: Sumit Mukherjee, Kaushiki Chatterjee
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 5 4 6 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 5 4 7 - 4
Targeting Signaling Pathways in Solid Tumors, Part A, Volume 385 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with t… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteTargeting Signaling Pathways in Solid Tumors, Part A, Volume 385 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more.
Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled
Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled
- Provides the latest information on cancer research
- Offers outstanding and original reviews on a range of cancer research topics
- Serves as an indispensable reference for researchers and students alike
Basic and translational cancer researchers. Physician scientists.
1. Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors
Rajiv Pathak, Rajni Kumari and Prajna Tripathi
2. Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression
Vivek Srivastava
3. Importance of targeting various cell signaling pathways in solid cancers
Chandrayee Ghosh
4. Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics
Subhajit Chatterjee
5. Factors affecting heterogeneity in breast cancer microenvironment: A narrative review
Sheila Spada
6. Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled
Anoop Kumar, Rajiv Pathak, Mohini Agarwal, Manish Kumar and Kumud Bala
Rajiv Pathak, Rajni Kumari and Prajna Tripathi
2. Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression
Vivek Srivastava
3. Importance of targeting various cell signaling pathways in solid cancers
Chandrayee Ghosh
4. Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics
Subhajit Chatterjee
5. Factors affecting heterogeneity in breast cancer microenvironment: A narrative review
Sheila Spada
6. Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled
Anoop Kumar, Rajiv Pathak, Mohini Agarwal, Manish Kumar and Kumud Bala
- No. of pages: 277
- Language: English
- Edition: 1
- Volume: 385
- Published: April 23, 2024
- Imprint: Academic Press
- Hardback ISBN: 9780443235467
- eBook ISBN: 9780443235474
SM
Sumit Mukherjee
I am a dynamic scientist with broad knowledge and research experience in cancer biology and cancer immunology. I am a highly skilled researcher with exceptional leadership and team-building capabilities. I have 10+ years of cancer research experience in academia as PhD student and Postdoctoral researcher. I have a track record of presenting and publishing scientific data in a timely and organized fashion as attested by my publication record of 12 published research articles with 6 as first-author. I am also a subject matter expert in preclinical cancer immunology as evidenced by my authored review articles with being co-corresponding author for one such review article. I have frequently peer-reviewed multiple articles for publication as peer-reviewer and guest editor. My Postdoctoral work focused on a novel immunosuppressive/protumor cancer cell expressing enzyme ART1’s discovery and further developing it as a therapeutic target in lung cancers and melanoma tumors utilizing murine in vivo models and patient samples. My doctoral research specialized in natural product-mediated (like curcumin) therapeutic intervention of cancers by modulating cancer cell signaling and cancer micro-environment immune system. My doctoral research also involved studying the mechanistic underpinning of cancer cell signaling & tumor microenvironment immunology for therapeutic targeting of brain tumors and cervical cancer models.
Affiliations and expertise
Cardiothoracic and Vascular Surgery,Albert Einstein College of Medicine BronxKC
Kaushiki Chatterjee
As a skilled scientist with expertise in cancer biology, stem cell biology, and epigenetics, I am deeply passionate about advancing scientific knowledge. In my current postdoctoral role, I investigate the role of disease-relevant histone modifiers in shaping the epigenetic landscape of stem cells. My active involvement in multiple projects demonstrates my commitment to collaboration and leveraging collective knowledge to achieve impactful results. I have a track record of mentoring students and actively encouraging diversity in STEM, especially among women pursuing research careers. In my doctoral research, I contributed to understanding the anti-tumor potential of plant polyphenols in cervical cancer. I have published several research and review articles in cancer biology and stem cell epigenetics Through my multifaceted contributions over the course of over 10 years, I aim to inspire the next generation of scientists while leaving a lasting impact on scientific endeavors.
Edit
Affiliations and expertise
Medicine Weill Cornell Medicine, New York